Misplaced Pages

Enoyl-acyl carrier protein reductase

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Enoyl ACP reductase) InterPro Family
Enoyl-acyl carrier protein reductase
Enoyl- reductase tetramer, Mycobacterium tuberculosis
Identifiers
EC no.1.3.1.9
CAS no.37251-08-4
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins

Enoyl-acyl carrier protein reductase (or ENR) (EC 1.3.1.9), is a key enzyme of the type II fatty acid synthesis (FAS) system. ENR is an attractive target for narrow-spectrum antibacterial drug discovery because of its essential role in metabolism and its sequence conservation across many bacterial species. In addition, the bacterial ENR sequence and structural organization are distinctly different from those of mammalian fatty acid biosynthesis enzymes.

At lower concentrations, Triclosan and Triclocarban provide a bacteriostatic effect by binding to ENR. Atromentin and leucomelone possess antibacterial activity, inhibiting the enzyme in the bacteria Streptococcus pneumoniae.

See also

References

  1. Kapoor M, Gopalakrishnapai J, Surolia N, Surolia A (August 2004). "Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum". The Biochemical Journal. 381 (Pt 3): 735–41. doi:10.1042/BJ20040302. PMC 1133883. PMID 15139852.
  2. Ling LL, Xian J, Ali S, Geng B, Fan J, Mills DM, Arvanites AC, Orgueira H, Ashwell MA, Carmel G, Xiang Y, Moir DT (May 2004). "Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase". Antimicrobial Agents and Chemotherapy. 48 (5): 1541–7. doi:10.1128/aac.48.5.1541-1547.2004. PMC 400533. PMID 15105103.
  3. Zheng CJ, Sohn MJ, Kim WG (December 2006). "Atromentin and leucomelone, the first inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae". The Journal of Antibiotics. 59 (12): 808–12. doi:10.1038/ja.2006.108. PMID 17323650.

External links

Metabolism: lipid metabolism / fatty acid metabolism, triglyceride and fatty acid enzymes
Synthesis
Malonyl-CoA synthesis
Fatty acid synthesis/
Fatty acid synthase
Fatty acid desaturases
Triacyl glycerol
Degradation
Acyl transport
Beta oxidation
General
Unsaturated
Odd chain
Other
To acetyl-CoA
Aldehydes
Oxidoreductases: CH–CH oxidoreductases (EC 1.3)
1.3.1: NAD/NADP acceptor
1.3.3: Oxygen acceptor
1.3.5: Quinone
1.3.99: Other acceptors
Enzymes
Activity
Regulation
Classification
Kinetics
Types
Portal: Category: